TW-37 is a novel nonpeptide inhibitor to recombinant Bcl-2, Bcl-xL and Mcl-1 with Ki of 0.29 μM, 1.11 μM and 0.26 μM, respectively.  TW-37 inhibits the growth of a broad range of cancer cells (such as breast, prostate, lymphoma, and pancreatic cancer

Numero articolo: BIOV2789-5
Unità di misura: 5 MG
https://grogg-prod.braintec.cloud/web/image/product.template/923760/image_1920?unique=2abe58c

146,00 CHF 146.0 CHF 146,00 CHF

146,00 CHF

Not Available For Sale

    Questa combinazione non esiste.

    Tempo di consegna attuale su richiesta

    Produttore: BIOVISION
    Numero del produttore: 2789-5
    Temperatura di stoccaggio: Freezer (-20)

    TW-37 is a novel nonpeptide inhibitor to recombinant Bcl-2, Bcl-xL and Mcl-1 with Ki of 0.29 μM, 1.11 μM and 0.26 μM, respectively.  TW-37 inhibits the growth of a broad range of cancer cells (such as breast, prostate, lymphoma, and pancreatic cancer